Sugarloaf Wealth Management, LLC Moderna, Inc. Transaction History

Sugarloaf Wealth Management, LLC

  • $460 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022
BUY
$126.46 - $235.05 $28,074 - $52,181
222 New
222 $38,000
Q2 2020

Jul 21, 2020
SELL
$29.67 - $80.0 $50,439 - $136,000
-1,700 Closed
0 $0
Q1 2020

Apr 15, 2020
BUY
$17.78 - $31.58 $30,226 - $53,686
1,700 New
1,700 $51,000

Others Institutions Holding MRNA

# of Institutions
1,113
Shares Held
241M
Call Options Held
9.26M
Put Options Held
12.1M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sugarloaf Wealth Management, LLC Portfolio

Follow Sugarloaf Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email